🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 45779A853 (prev. 45779A101 )
- Market Cap
- Micro Cap
- IPO
- 4/10/2013 · $2.00/share
Business: InspireMD, Inc. is a commercial-stage medical device company with proprietary and innovative embolic prevention systems (EPS)/thrombus management technologies and neurovascular devices that seek to overcome the harmful consequences of conventional stenting.
Notes: March 26, 2019 -- InspireMD, Inc. (NYSE American: NSPR, NSPR.WS, NSPR.WSB), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced that its Board of Directors has approved a one-for-fifty reverse stock split of its common stock that is scheduled to become effective after trading closes on March 29, 2019. Beginning on April 1, 2019, the Company’s common stock will trade on the NYSE American on a split adjusted basis under a new CUSIP number 45779A853.
Company Contact
- CEO
- Marvin Slosman
- CFO
- Craig Shore
- Investor Relations
- Craig Shore · 888-776-6804 · Investor-Relations@inspiremd.com